Multivessel TALENT

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1550 participants.

Also called NCT04390672

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,550 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04390672
Other papers using this trial's data
  • Standardised versus visual assessment of device success after percutaneous coronary intervention EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2026-10-05 DOI, PubMed 42837202, PMC13617451 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Ireland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04390672. Randomized; no masking; primary purpose treatment. Start 2020-09-22 (actual); primary completion 2025-09-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multivessel TALENT
Condition
Myocardial Ischemia
Condition
Coronary Disease
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Condition
Arterial Occlusive Diseases
Condition
Vascular Diseases
Intervention (Device)
SUPRAFLEX Cruz
Intervention (Device)
SYNERGY
Lead sponsor
National University of Ireland, Galway, Ireland (class: other)

Record details

Record id
cardio:ct-nct04390672
Content hash
78c196ad6bc20e23bb227e045a23d512d801086e94fa579197ff4ea11a68a5f6